Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic anti-VEGF in age-related macular degeneration: Ranibizumab and Bevacizumab controversy.

× No keyword cloud information.

5 in total

1. Functional and anatomic consequences of subretinal dosing in the cynomolgus macaque.

Authors: T Michael Nork; Christopher J Murphy; Charlene B Y Kim; James N Ver Hoeve; Carol A Rasmussen; Paul E Miller; Hugh D Wabers; Michael W Neider; Richard R Dubielzig; Ryan J McCulloh; Brian J Christian
Journal: Arch Ophthalmol Date: 2011-09-12

2. Provider, patient and public benefits from a NICE appraisal of bevacizumab (Avastin).

Authors: Catherine Rhodes; John Harris; John Sulston; Catherine Spanswick
Journal: J Med Ethics Date: 2011-09-24 Impact factor: 2.903

3. Mechanisms controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization.

Authors: Wei-Li Chen; Yan-Ming Chen; Hsiao-Sang Chu; Chung-Tien Lin; Lu-Ping Chow; Chih-Ta Chen; Fung-Rong Hu
Journal: PLoS One Date: 2014-04-08 Impact factor: 3.240

4. Aflibercept for the treatment of age-related macular degeneration.

Authors: George Trichonas; Peter K Kaiser
Journal: Ophthalmol Ther Date: 2013-06-25

5. Gene profiling of human VEGF signaling pathways in human endothelial and retinal pigment epithelial cells after anti VEGF treatment.

Authors: Shani Golan; Michal Entin-Meer; Yonathan Semo; Sofia Maysel-Auslender; Daphna Mezad-Koursh; Gad Keren; Anat Loewenstein; Adiel Barak
Journal: BMC Res Notes Date: 2014-09-08

5 in total